Contract analysis

I. Executive Summary This memorandum follows the successful resolution of the Internal Revenue Service Large Business & International Division ("LB&I") examination of the transfer pricing practices of Penterra Pharmaceuticals Corp. ("PPC" or the "Company") for tax years 2017 through 2020 (Exam Team LB&I-NE-TP-2022-00641). The purpose of this memorandum is to analyze whether PPC should pursue a bilateral advance prici

II. Background — Summary of the Resolved Examination Before turning to the APA analysis, we briefly summarize the intercompany arrangements that were the subject of the recently concluded IRS examination and the terms of the resolution. This context is important because it directly informs the scope, strategy, and potential leverage for a prospective APA. A. The IP Structure Under Scrutiny PPC's international tax str

1. CSA Cost-Sharing Ratio Adjustments ($235.01 million): The IRS examination team contended that PBI's cost-sharing ratios should be increased to reflect a higher share of reasonably anticipated benefits, based on the IRS economist's alternative revenue projections and comparable profit-split methodologies. The IRS's proposed ratios ranged from approximately 45% to 52% for the examination years.

2. Legacy IP Royalty Rate Increase ($188.04 million): The IRS proposed increasing the legacy IP royalty rate from PPC's self-reported rate of 4.5% to 11.0% of non-Americas net sales, based on the IRS economist's selection of a different set of comparable uncontrolled transactions and a different statistical measure (mean versus median).

3. Economic Substance Challenge: The IRS initially challenged PBI's economic substance, asserting that PBI lacked sufficient employees, decision-making authority, and operational independence to be respected as the beneficial owner of the non-Americas IP rights. The IRS ultimately did not pursue this position to a formal notice of proposed adjustment ("NOPA"), effectively conceding the point in light of the substanti

4. Correlative Offset ($-42.65 million): A downward correlative adjustment offsetting a portion of the proposed upward adjustments, reflecting the mechanical interaction of the various adjustments. The net proposed adjustment was $380.4 million, with a proposed IRC § 6662(e) substantial valuation misstatement penalty of approximately $15.98 million. Examination Defense. C&H, in collaboration with WVG and T&K, defende

III. Overview of Advance Pricing Agreements A. Definition and Purpose An advance pricing agreement is a binding agreement between a taxpayer and one or more taxing authorities that establishes an agreed-upon transfer pricing methodology — or, in some cases, a specific arm's-length range or result — for specified controlled transactions for a fixed prospective period, typically five years. The APA concept is grounded

1. Unilateral APA. A unilateral APA is an agreement between the taxpayer and a single taxing authority — in PPC's case, the IRS alone. A unilateral APA binds only the IRS and PPC; it does not bind Irish Revenue or any other foreign tax authority. While a unilateral APA provides certainty for U.S. federal income tax purposes, it carries a significant risk of double taxation if the foreign jurisdiction disagrees with t

2. Bilateral APA. A bilateral APA is an agreement involving the taxpayer and two taxing authorities — in PPC's case, the IRS and Irish Revenue. The bilateral APA is negotiated through the competent authority process established under the applicable income tax treaty — here, Article 25 (Mutual Agreement Procedure) of the U.S.-Ireland Income Tax Treaty (Convention between the Government of the United States of America

3. Multilateral APA. A multilateral APA involves three or more taxing jurisdictions. This format is appropriate where the intercompany transactions at issue involve related parties in three or more countries. In PPC's case, a multilateral APA is not likely to be necessary, given that the primary transfer pricing transactions at issue are between PPC (United States) and PBI (Ireland). PHL, the Luxembourg intermediate

1. The CSA Cost-Sharing Arrangement. The APA would establish the agreed methodology for determining PBI's cost-sharing payments under the CSA, including the formula for computing cost-sharing ratios based on reasonably anticipated benefits, the definition of the qualified R&D cost pool, and the treatment of any adjustments necessitated by changes in product mix or territory economics. This was the largest source of p

2. The Legacy IP Royalty Arrangement. The APA would establish the agreed methodology for determining the arm's-length royalty rate for pre-2012 legacy compounds licensed by PPC to PBI. This was the second-largest source of proposed IRS adjustments ($188.04 million). Given the IRS's aggressive position (11.0%) versus PPC's position (4.5%), obtaining prospective certainty on this issue is particularly valuable.

3. The PMI Contract Manufacturing Arrangement. Although the PMI arrangement was not a primary focus of the TY 2017–2020 examination, including it in the APA would provide comprehensive coverage of PPC's Irish intercompany transactions and eliminate any risk of future examination of the cost + 8% markup. We note that the PCT payment itself ($312 million, paid in 2012) is a historical transaction and would not be direc

IV. Advantages of Pursuing a Bilateral APA The potential benefits of a bilateral APA for PPC are substantial and multifaceted. We discuss each category below. A. Prospective Certainty on Transfer Pricing The most significant advantage of an APA is the prospective certainty it provides. For the duration of the APA term — typically five years, with the possibility of a rollback to prior open years — PPC would have bind

V. Disadvantages and Risks of Pursuing a Bilateral APA While the advantages of a bilateral APA are compelling, PPC should also carefully consider the disadvantages and risks associated with the process. We address each category below. A. Significant Time Investment Bilateral APAs are complex undertakings that typically require two to four years to negotiate and finalize. IRS APA Program statistics indicate that the m

VI. Procedural Overview — Bilateral APA Process This section provides a more detailed overview of the procedural steps involved in pursuing a bilateral APA with the IRS and Irish Revenue. A. IRS APA Program (Rev. Proc. 2015-41) The IRS APA process is administered by the APMA program within LB&I and proceeds through the following stages:

1. Pre-Filing Conference. The first formal step in the APA process is a pre-filing conference with the IRS APMA program. PPC and C&H would submit a written request for a pre-filing conference, identifying (at PPC's election) the taxpayer on an anonymous or identified basis. The pre-filing conference is an informal, confidential meeting with APMA staff that allows for a preliminary discussion of the proposed covered t

2. APA Request (Form 14661). Following the pre-filing conference, and assuming PPC decides to proceed, PPC would file a formal APA request with the APMA program using IRS Form 14661 (Application for Advance Pricing Agreement). The APA request is a comprehensive submission that includes the following components: • A detailed description of the controlled transactions proposed to be covered by the APA, including the CS

3. IRS Evaluation and Due Diligence. Upon receipt of the APA request, the APMA team assigns an APA team leader and team economist to the case. The APMA team reviews the submission in detail, conducts its own independent economic analysis, and may issue supplemental information requests to PPC. The due diligence phase can take several months to a year, depending on the complexity of the issues and the responsiveness o

4. Competent Authority Negotiation. For a bilateral APA, the IRS competent authority (a function housed within the APMA program) initiates negotiations with the Irish Revenue competent authority under Article 25 of the U.S.-Ireland Income Tax Treaty. The competent authority negotiation is a government-to-government process in which the two taxing authorities exchange position papers, data analyses, and proposed terms

5. Draft APA Agreement. Once the competent authorities reach agreement on the transfer pricing methodology and terms, a draft APA agreement is prepared. The draft is shared with PPC for review and comment. The APA agreement sets forth the covered transactions, the agreed methodology, the APA term, the critical assumptions, and the annual compliance reporting obligations.

6. Execution. The final APA is executed by PPC, the IRS, and (through the competent authority process) Irish Revenue. Upon execution, PPC is obligated to apply the agreed methodology for each year of the APA term and to file annual compliance reports as described in Section VI.D below. B. Irish Revenue APA/MAP Process On the Irish side, the competent authority process is administered by the Large Cases Division of th

VII. Scope of the Proposed APA A. Covered Transactions Based on our analysis of PPC's intercompany arrangements and the issues raised during the TY 2017–2020 examination, C&H recommends that the APA cover the following three categories of controlled transactions:

1. CSA Cost-Sharing Arrangement. The APA would establish the agreed methodology for determining PBI's cost-sharing payments under the CSA between PPC and PBI. Specifically, the APA would address: • The formula for computing the reasonably anticipated benefit split between PPC (Americas) and PBI (non-Americas), including the revenue metrics, time horizons, and discount rates used to project relative benefits; • The de

2. Legacy IP Royalty. The APA would establish the agreed methodology for determining the arm's-length royalty rate applicable to the pre-2012 legacy compounds licensed by PPC to PBI. PPC's current position, which was substantially validated by the examination settlement, is a royalty rate of 4.5% of non-Americas net sales. This rate is supported by WVG's CUT analysis, which identified 14 comparable uncontrolled pharm

3. PMI Contract Manufacturing. C&H recommends that PPC consider including the PMI contract manufacturing arrangement in the APA, even though this transaction was not a primary focus of the TY 2017–2020 examination. Including the PMI arrangement would provide comprehensive coverage of PPC's intercompany transactions with its Irish operations and would eliminate any future audit risk associated with the cost + 8% marku

VIII. Strategic Considerations Specific to PPC A. Leverage from Recent Examination The favorable resolution of the TY 2017–2020 examination provides PPC with meaningful strategic leverage in the APA process. Several aspects of this leverage merit emphasis: Validation of PPC's Approach. The settlement at 12.51% of proposed adjustments effectively validates PPC's overall transfer pricing methodology and the arm's-lengt